FinDogFinDog
Friday, October 30, 2026Closing data · 4:00 PM ET
English
Log in

BDX

Becton DickinsonNYSE · Health Care Equipment · Health Care
Previous close
197.88
Change
−0.46 / −0.23%
FinDog View
Neutral
52-Week Range ?
140.11 – 213.08
P/E (TTM) ?
57.4
Forward P/E ?
13.8
Based on consensus earnings for the next 12 months
Market Cap
$54.0B
1M
+10.55%
S&P 500 −0.91% over same period
Volume / Avg Volume
2.9M / 1.4M
2.05× average
Latest earnings analysisFY2026 Q3Reported 2026-08-06

BDX Q3 FY2026: revenue up 5.4%, adjusted EPS beat, guidance midpoint raised

BD's fiscal third quarter was a beat-and-raise: adjusted EPS of $3.23 topped the $3.17 consensus, revenue rose 5.4% to $4.98 billion, and management lifted the midpoint of full-year adjusted EPS guidance. Gross margin slipped to 46.5% and GAAP net income fell 34.3% to $377 million on a discontinued-operations loss, so read the adjusted headline next to the GAAP one.

Read the full analysis →
Revenue$4.98BYoY +5.40%
EPS (non-GAAP)$3.23Beatest. $3.17
Next-day move−0.12%

Price History

Closing price · USD1M6M1Y5Y
1701801902002102026-092026-102026-102026-102026-10

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 40.11M6M1Y5Y
2030405060702023-082024-062025-032026-012026-10

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis

Next Earnings

Date and consensus from the earnings calendar; the analysis is generated automatically after the releaseEarnings Calendar →
Report date
2026-11-05
in 4 days · Pre-market
Consensus EPS
$4.11
Last quarter EPS $3.23
Avg. next-day move over the last 5 reports
±4.4%

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 96 of its 5-year rangeExpensive
5-year range 25.9 – 57.2 · Median 40.1
Last 4 quarters: $2.5B in buybacks + $1.2B in dividends, 6.80% of market cap combined
P/E (TTM)
57.4
P/B
2.2
P/S
2.6
Dividend Yield
1.59%
Earnings Reaction
Over the last 5 reports, the stock moved ±4.4% on average on the first trading day after, rising 2 times
Most recent −0.12%
Volatility & Correlation
1-year beta 0.32 · Correlation with S&P 500 0.13Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 5 · $1.3MNet selling $1.3M
  • 10-26Feld MichaelEVP, Chief Revenue OfficerSell$0.02M76 shares · Avg price 198.13
  • 09-28Feld MichaelEVP, Chief Revenue OfficerSell$0.01M76 shares · Avg price 183.70
  • 08-26Feld MichaelEVP, Chief Revenue OfficerSell$0.03M165 shares · Avg price 188.49
  • 08-13Polen Thomas E JrChairman, CEO and PresidentSell$0.77M4,152 shares · Avg price 185.00
  • 08-11Goette RolandEVP and President, EMEASell$0.44M2,438 shares · Avg price 180.84
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2026 Q34.98+5.4%46.5%0.660.38—1.37
FY2026 Q24.71+5.2%45.7%0.09-0.31—-1.11
FY2026 Q15.25+1.6%45.9%0.550.380.551.34
FY2025 Q47.47+37.3%48.1%1.000.49—1.71
FY2025 Q34.73−5.3%47.3%0.740.57—2.00
FY2025 Q24.48−11.2%41.5%0.380.31—1.07
FY2025 Q15.17+9.8%43.2%0.450.300.591.04
FY2024 Q45.44+6.9%45.7%0.620.40—1.37
FY2024 Q34.99+2.3%46.2%0.600.49—1.68
FY2024 Q25.05+4.6%45.7%0.730.54—1.85
FY2024 Q14.71+2.6%43.1%0.440.28—0.96
FY2023 Q45.09+6.8%33.5%0.350.11—0.35

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView